Evidence map›Paper›PMID 30032427›Full record

ArticleDiabetologia2018

MANF protects human pancreatic beta cells against stress-induced cell death.

Elina Hakonen, Vikash Chandra, Christopher L Fogarty, Nancy Yiu-Lin Yu, Jarkko Ustinov, Shintaro Katayama, Emilia Galli, Tatiana Danilova, Päivi Lindholm, Aki Vartiainen and 6 more

Open access · hybridAbstract read
In one paragraph

Article in Diabetologia, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
9.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 88 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Dual role of neuroplastin in pancreatic β cells: Regulating insulin secretion and promoting islet inflammation.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 4 countries.

Elina HakonenResearch Programs Unit, Molecular Neurology, Biomedicum Helsinki, University of Helsinki, PO Box 63, (Haartmaninkatu 8), 00014, Helsinki, Finland.
Vikash ChandraResearch Programs Unit, Molecular Neurology, Biomedicum Helsinki, University of Helsinki, PO Box 63, (Haartmaninkatu 8), 00014, Helsinki, Finland. vikash.chandra@helsinki.fi.
Christopher L FogartyClinicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Nancy Yiu-Lin YuDepartment of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden.
Jarkko UstinovResearch Programs Unit, Molecular Neurology, Biomedicum Helsinki, University of Helsinki, PO Box 63, (Haartmaninkatu 8), 00014, Helsinki, Finland.
Shintaro KatayamaDepartment of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden.
Emilia GalliResearch Program in Developmental Biology, Institute of Biotechnology, University of Helsinki, Helsinki, Finland.
Tatiana DanilovaResearch Program in Developmental Biology, Institute of Biotechnology, University of Helsinki, Helsinki, Finland.
Päivi LindholmResearch Program in Developmental Biology, Institute of Biotechnology, University of Helsinki, Helsinki, Finland.
Aki VartiainenResearch Programs Unit, Molecular Neurology, Biomedicum Helsinki, University of Helsinki, PO Box 63, (Haartmaninkatu 8), 00014, Helsinki, Finland.
Elisabet EinarsdottirDepartment of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden.
Kaarel KrjutškovDepartment of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden.
Juha KereResearch Programs Unit, Molecular Neurology, Biomedicum Helsinki, University of Helsinki, PO Box 63, (Haartmaninkatu 8), 00014, Helsinki, Finland.
Mart SaarmaResearch Program in Developmental Biology, Institute of Biotechnology, University of Helsinki, Helsinki, Finland.
Maria LindahlResearch Program in Developmental Biology, Institute of Biotechnology, University of Helsinki, Helsinki, Finland.
Timo OtonkoskiResearch Programs Unit, Molecular Neurology, Biomedicum Helsinki, University of Helsinki, PO Box 63, (Haartmaninkatu 8), 00014, Helsinki, Finland. timo.otonkoski@helsinki.fi.ORCID http://orcid.org/0000-0001-9190-2496
University of Helsinki · FIKarolinska Institutet · SE

Funding

Innovative Medicines Initiative 2 (INNODIA) 115797Juvenile Diabetes Research Foundation International 17-2013-410
6 · The paper itself

Abstract

aims/hypothesisThere is a great need to identify factors that could protect pancreatic beta cells against apoptosis or stimulate their replication and thus prevent or reverse the development of diabetes. One potential candidate is mesencephalic astrocyte-derived neurotrophic factor (MANF), an endoplasmic reticulum (ER) stress inducible protein. Manf knockout mice used as a model of diabetes develop the condition because of increased apoptosis and reduced proliferation of beta cells, apparently related to ER stress. Given this novel association between MANF and beta cell death, we studied the potential of MANF to protect human beta cells against experimentally induced ER stress.

methodsPrimary human islets were challenged with proinflammatory cytokines, with or without MANF. Cell viability was analysed and global transcriptomic analysis performed. Results were further validated using the human beta cell line EndoC-βH1.

resultsThere was increased expression and secretion of MANF in human beta cells in response to cytokines. Addition of recombinant human MANF reduced cytokine-induced cell death by 38% in human islets (p < 0.05). MANF knockdown in EndoC-βH1 cells led to increased ER stress after cytokine challenge. Mechanistic studies showed that the protective effect of MANF was associated with repression of the NF-κB signalling pathway and amelioration of ER stress. MANF also increased the proliferation of primary human beta cells twofold when TGF-β signalling was inhibited (p < 0.01). CONCLUSIONS/

interpretationOur studies show that exogenous MANF protein can provide protection to human beta cells against death induced by inflammatory stress. The antiapoptotic and mitogenic properties of MANF make it a potential therapeutic agent for beta cell protection.

Indexed as

Endoplasmic Reticulum StressAstrocytesCell DeathCell ProliferationCells, CulturedCell SurvivalCytokinesEndoplasmic ReticulumHumansInflammationInsulin-Secreting CellsIslets of LangerhansNerve Growth FactorsNF-kappa BRecombinant ProteinsRNA, Small InterferingCytokinesMANF protein, humanNerve Growth FactorsNF-kappa BRecombinant ProteinsRNA, Small InterferingBeta cell proliferationBeta cell protectionEndoplasmic reticulum stressMesencephalic astrocyte-derived neurotrophic factor (MANF)NF-κB

Identifiers

PMID30032427
PMCPMC6133171
OpenAlexW2883439525

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.